Changing kidney allocation policy in France: the value of simulation.
This paper advocates the value of simulation to promote changes in kidney allocation. Due to the scarcity of organs and to the competition between transplantation centers to obtain the best organs for their patients, any change in organ allocation policy remains a sensitive issue in public health decision-making. Organ allocation is not easily available for prospective experimental study. Observational stud-ies only support limited changes. A simulation tool in this context permits the comparison of observed results against simulated ones. In our experience in France, it has shown to be a helpful tool during the allocation design phase providing objective facts for the debates and increasing the potential for change.
Jacquelinet
Christian
C
Direction Médicale et Scientifique, Agence de la Biomédecine, 1, avenue du Stade de France, 93212 Saint-Denis La Plaine Cedex France. christian.jacquelinet@biomedecine.fr
Audry
Benoît
B
Golbreich
Christiine
C
Antoine
Corinne
C
Rebibou
Jean-Michel
JM
Claquin
Jacky
J
Loty
Bernard
B
D005602:France; D006291:Health Policy; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation; D008962:Models, Theoretical; D040841:Resource Allocation / Q000331:legislation & jurisprudence / Q000379:methods*; D009927:Tissue and Organ Procurement / Q000331:legislation & jurisprudence / Q000379:methods*